首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
USE OF 5-FLUORODEOXYURIDINE (FUDR) AS AN ADJUVANT TO SURGICAL MANAGEMENT OF CARCINOMA OF STOMACH
被引:0
作者
:
SERLIN, O
论文数:
0
引用数:
0
h-index:
0
机构:
Surgical Service, VA Hospital, East Orange, New Jersey
SERLIN, O
WOLKOFF, JS
论文数:
0
引用数:
0
h-index:
0
机构:
Surgical Service, VA Hospital, East Orange, New Jersey
WOLKOFF, JS
AMADEO, JM
论文数:
0
引用数:
0
h-index:
0
机构:
Surgical Service, VA Hospital, East Orange, New Jersey
AMADEO, JM
KEEHN, RJ
论文数:
0
引用数:
0
h-index:
0
机构:
Surgical Service, VA Hospital, East Orange, New Jersey
KEEHN, RJ
机构
:
[1]
Surgical Service, VA Hospital, East Orange, New Jersey
[2]
Surgical Service, Va Hospital, Cleveland, Ohio
[3]
Surgical Service, VA Hospital, San Juan
[4]
National Research Council, Washington, District of Columbia
来源
:
CANCER
|
1969年
/ 24卷
/ 02期
关键词
:
D O I
:
10.1002/1097-0142(196908)24:2<223::AID-CNCR2820240203>3.0.CO;2-U
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
5‐Fluorodeoxyuridine was administered to 185 patients randomized to the treated group following gastric resection for carcinoma of the stomach. Two hundred twelve patients were randomized to control groups. There are no significant differences in operative mortality, complications, or 3‐year survival rates. Copyright © 1969 American Cancer Society
引用
收藏
页码:223 / &
相关论文
共 4 条
[1]
ANSFIELD FJ, 1960, CANC CHEMOTHER REP, V6, P21
[2]
MOORE GE, 1960, CANCER CHEMOTH REP, V6, P26
[3]
YOUNG CW, 1960, CANC CHEMOTHER REP, V6, P17
[4]
1965, CANCER, V18, P291
←
1
→
共 4 条
[1]
ANSFIELD FJ, 1960, CANC CHEMOTHER REP, V6, P21
[2]
MOORE GE, 1960, CANCER CHEMOTH REP, V6, P26
[3]
YOUNG CW, 1960, CANC CHEMOTHER REP, V6, P17
[4]
1965, CANCER, V18, P291
←
1
→